ROIV · US market

Roivant Sciences Ltd

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$25.64bnFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E-96.31×

Latest-quarter run-rate P/E-33.77×

Trailing P/S3404.47×

Latest-quarter run-rate P/S4445.64×

Calculation inputs

Trailing earnings: -US$266.25m
Latest-quarter run-rate earnings: -US$759.35m
Latest fiscal-year earnings: -US$299.77m
Trailing revenue: US$7.53m
Latest-quarter run-rate revenue: US$5.77m
Latest fiscal-year revenue: US$8.26m

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

PTH · Invesco Dorsey Wright Healthcare Momentum ETF4.94% weight · Holdings dated 19 August 2026
GDOC · Goldman Sachs Future Health Care Equity ETF2.39% weight · Holdings dated 31 May 2026
XMMO · Invesco S&P MidCap Momentum ETF1.92% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
BMED · iShares Health Innovation Active ETF1.36% weight · Holdings dated 21 August 2026
IBB · iShares Biotechnology ETF1.32% weight · Holdings dated 19 August 2026
XBI · State Street SPDR S&P Biotech ETF1.15% weight · Holdings dated 21 August 2026
PXSAX · Impax Small Cap Fund Class A1.12% weight · Holdings dated 30 June 2026
PAMC · Pacer Lunt Midcap Multi-Factor Alternator ETF1.02% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
QQQJ · Invesco NASDAQ Next Gen 100 ETF1.00% weight · Holdings dated 31 May 2026
PEEAX · PGIM Jennison Mid-Cap Growth Fund- Class A0.95% weight · Holdings dated 29 May 2026

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.